Advisory Committee on Immunization Practices
Recommendations for use of Haemophilus b conjugate vaccines and a combined diphtheria, tetanus, pertussis, and Haemophilus b vaccine. Recommendations of the advisory Committee on Immunization Practices (ACIP)
Abstract
These recommendations include information on two vaccines recently licensed for use among infants: Haemophilus b Conjugate Vaccine (PRP-T [ActHIB, OmniHIB]), manufactured by Pasteur Mérieux Vaccins, and TETRAMUNE, manufactured by Lederle Laboratories/Praxis Biologics. This statement also updates recommendations for use of other available Haemophilus b vaccines (PRP-D [ProHIBiT]; HbOC [HibTITER]; and PRP-OMP [PedvaxHIB]) for infants and children.
Source and rights
Published by MMWR. Recommendations and reports : Morbidity and mortality weekly report. Recommendations and reports, 1993. The guideline itself is at the source linked here.
Prognia summarises this guideline for reference and education. It is not medical advice. Always check the official guideline and current local protocols before acting on it.
At a glance
- Organisation
- Advisory Committee on Immunization Practices
- Published
- 1993
- Applies to
- 🇺🇸 United States
- Scope
- National
- Journal
- MMWR. Recommendations and reports : Morbidity and mortality weekly report. Recommendations and reports
- PubMed
- 8145705
- Added to Prognia
- 24 July 2026